Tags

Type your tag names separated by a space and hit enter

Vulvovaginal candidiasis in a Flemish patient population.
Clin Microbiol Infect. 2005 Dec; 11(12):1005-11.CM

Abstract

Increased resistance to fluconazole has been reported in oral, oesophageal and urinary Candida isolates, but this has not been observed commonly in genital tract isolates. The rate of isolation of Candida spp. and their susceptibility to amphotericin B, flucytosine and azoles were determined in a number of clinical practices in the city of Ghent, Belgium. Patients with symptomatic vulvovaginal candidiasis (VVC) were treated with fluconazole, and the mycological and clinical outcomes were evaluated. Isolates were identified as Candida albicans (78.6%), Candida guilliermondii (17.3%), Candida glabrata (2.6%) and Candida dubliniensis (1.3%). The rates of mycological and clinical cures were 79.5% and 100%, respectively. Women with recurrent VVC were infected more frequently by non-albicans Candida spp., but no association was found between the use of antifungal agents and the presence of non-albicans spp. In-vitro resistance to fluconazole was not detected, even among subsequent Candida isolates from nine patients for whom mycological cure was not achieved.

Authors+Show Affiliations

Laboratory for Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16307555

Citation

De Vos, M M., et al. "Vulvovaginal Candidiasis in a Flemish Patient Population." Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 11, no. 12, 2005, pp. 1005-11.
De Vos MM, Cuenca-Estrella M, Boekhout T, et al. Vulvovaginal candidiasis in a Flemish patient population. Clin Microbiol Infect. 2005;11(12):1005-11.
De Vos, M. M., Cuenca-Estrella, M., Boekhout, T., Theelen, B., Matthijs, N., Bauters, T., Nailis, H., Dhont, M. A., Rodriguez-Tudela, J. L., & Nelis, H. J. (2005). Vulvovaginal candidiasis in a Flemish patient population. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 11(12), 1005-11.
De Vos MM, et al. Vulvovaginal Candidiasis in a Flemish Patient Population. Clin Microbiol Infect. 2005;11(12):1005-11. PubMed PMID: 16307555.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vulvovaginal candidiasis in a Flemish patient population. AU - De Vos,M M, AU - Cuenca-Estrella,M, AU - Boekhout,T, AU - Theelen,B, AU - Matthijs,N, AU - Bauters,T, AU - Nailis,H, AU - Dhont,M A, AU - Rodriguez-Tudela,J L, AU - Nelis,H J, PY - 2005/11/26/pubmed PY - 2006/1/21/medline PY - 2005/11/26/entrez SP - 1005 EP - 11 JF - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases JO - Clin Microbiol Infect VL - 11 IS - 12 N2 - Increased resistance to fluconazole has been reported in oral, oesophageal and urinary Candida isolates, but this has not been observed commonly in genital tract isolates. The rate of isolation of Candida spp. and their susceptibility to amphotericin B, flucytosine and azoles were determined in a number of clinical practices in the city of Ghent, Belgium. Patients with symptomatic vulvovaginal candidiasis (VVC) were treated with fluconazole, and the mycological and clinical outcomes were evaluated. Isolates were identified as Candida albicans (78.6%), Candida guilliermondii (17.3%), Candida glabrata (2.6%) and Candida dubliniensis (1.3%). The rates of mycological and clinical cures were 79.5% and 100%, respectively. Women with recurrent VVC were infected more frequently by non-albicans Candida spp., but no association was found between the use of antifungal agents and the presence of non-albicans spp. In-vitro resistance to fluconazole was not detected, even among subsequent Candida isolates from nine patients for whom mycological cure was not achieved. SN - 1198-743X UR - https://www.unboundmedicine.com/medline/citation/16307555/Vulvovaginal_candidiasis_in_a_Flemish_patient_population_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1198-743X(14)62396-X DB - PRIME DP - Unbound Medicine ER -